Funder: Sontag Foundation
Due Dates (Anticipated): September 2026 (Full application deadline)
Funding Amounts: $50,000 for one year; supports research expenses and travel to the ASCO Annual Meeting.
Summary: Funds early-career research integrating engineered NK cells and IL-12-expressing oncolytic virus for novel glioblastoma therapies.